Sagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer
PUBLIC · SGMTApr 21, 2026
Position
Chief Medical Officer
Company
Sagimet
Andreas Grauer
San MateoBiotechnologyHealth CarePharmaceuticalBiopharma
Description
On April 20, 2026, Sagimet Biosciences announced the appointment of Andreas Grauer, M.D. as Chief Medical Officer, effective immediately. This follows the retirement of Eduardo Martins, M.D., who will continue to support the company as an external scientific advisor.
Who to call at Sagimet, and when
A new leader at Sagimet brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Sagimet raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Sagimet, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sagimet. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Sagimet
Location
San Mateo, California, United States
About
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a platform of proprietary FASN inhibitors. For more information, please visit www.sagimet.com.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sagimet changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San MateoBiotechnologyHealth CarePharmaceuticalBiopharma